Skip to Main Content.
Human Subjects site of Office of Research Support link to UT home link to Office of Research Support

The Office of Research Support (ORS) does not administer or oversee HOP policy 5-2011 or training related to the policy. ORS administers HOP policy 7-1210, “Promoting Objectivity in Research by Managing, Reducing or Eliminating Financial Conflicts of Interest” so if you conduct research and have:

  1. Not submitted a Financial Interest Disclosure (FID), you will need to complete mandatory training and file a FID. Instructions for completing these requirements are located at
  2. Previously submitted a FID, you are not required to complete additional training nor re-disclose the same information to comply with the UTS 180/HOP 5-2011 policy requirements.   However, you may have other responsibilities under that policy.

HOP policy 5-2011 QUESTIONS? Contact the Provost’s Office or call Mike Kerker, Associate Vice Provost at (512) 471-2694.

IRB Review Timeline

Once a PI completes and submits an IRB electronic submission, the study is automatically routed for additional electronic signatures, from designated faculty members

Designated faculty members for student research = Faculty sponsor + DRC
Designated faculty members for faculty research = DRC

These faculty members are automatically notified via email that a study is awaiting their electronic signature (approval).  PIs who are concerned about the time frame for their study’s approval should contact these faculty members to ensure that their study is signed promptly.  Only after these signatures have been obtained will the Office of Research Support be notified that a study is officially submitted and ready for processing.

Exempt studies, posing minimal risk to human subjects, take approximately 2-3 weeks to be processed from the date received by ORS. Expedited studies take approximately 3-4 weeks to be processed from the date received by ORS. These processing timelines relate to when ORS staff provide feedback to the PIs regarding any actions that may be needed in preparing the study for IRB review and approval. An IRB approval timeline cannot be provided as it will vary from one submission to another.

It is important to remember that both exempt and expedited studies are reviewed "in house," and thus, the full board does not review them. Therefore, the full board meeting and agenda dates and deadlines are not applicable to exempt and expedited studies. Full board studies are reviewed monthly. Each meeting has a corresponding agenda deadline. A study must be submitted on or before the agenda deadline to be reviewed by the board at that month's meeting. Notification of determinations reached at the full board meetings are mailed to PIs within two weeks after the meeting date.

graphic of review, risk and timeline